China National Medicines Corp Ltd (600511.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Distributors · China · ISIN CNE000001D56

Price
27.54 CNY
Market cap
20.78 bn CNY
P/E (2025)
10.41
P/S (2025)
0.40
Dividend yield
2.90 %
Net margin
3.81 %
Return on equity (ROE)
9.83 %
Return on assets (ROA)
5.44 %

China National Medicines Corp Ltd financials

Fiscal year20242025
Revenue50.60 bn CNY52.47 bn CNY
Gross profit3.59 bn CNY3.46 bn CNY
Operating income2.68 bn CNY2.62 bn CNY
EBIT2.10 bn CNY2.63 bn CNY
Net income2.00 bn CNY2.00 bn CNY
Diluted EPS – continuing operations2.65 CNY2.65 CNY

Full history since 1999, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About China National Medicines Corp Ltd

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co. Ltd.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.